首页> 外国专利> STABLE PREPARATION OF RECOMBINANT FACTOR VIII WITHOUT ALBUMIN THAT HAS A LOW SUGAR CONTENT.

STABLE PREPARATION OF RECOMBINANT FACTOR VIII WITHOUT ALBUMIN THAT HAS A LOW SUGAR CONTENT.

机译:稳定地制备不含糖含量低的白蛋白的重组因子VIII。

摘要

A STABILIZED FORMULATION OF RECOMBINANT FACTOR VIII (RFVIII) IS PRESENT, FREE OF ALBUMINE, IN LYOPHILIZED FORM, WHICH HAS AMORPHOUS AND CRYSTALLINE COMPONENTS, AND INCLUDES, WHEN RECONSTITUTED IN WATER, APPROX. BETWEEN 65 AND 400 MM OF GLYCINE, UP TO 50 MM OF HISTIDINE, BETWEEN 15 AND 60 MM OF SUCROSA, UP TO 50 MM OF NACL, UP TO 5 MM OF CACL {SUB, 2}, AND BETWEEN 50 AND 1500 IU / ML OF RFVIII. AN ESPECIALLY PREFERRED FORMULATION INCLUDES AFTER RECONSTITUTION WITH WATER, APPROX. 290 MM OF GLYCINE, 20 MM OF HISTIDINE, 30 MM OF SUCROSA, 30 MM OF NACL, 2.5 MM OF CACL {SUB, 2} AND BETWEEN 50 AND 1500 IU / ML OF RFVIII. THE RESIDUAL WATER CONTENT OF THE LYOPHILIZED PREPARATION IS APPROX. BETWEEN 1 AND 3% BY WEIGHT, PREFERABLY APPROX. 1% BY WEIGHT.
机译:重组因子VIII(RFVIII)的稳定配方目前已存在,无磷化形式的尿素,该化合物具有无定形和晶体成分,并且在水中复溶时包括在内。在65和400毫米的甘氨酸之间,最多50毫米的组氨酸之间,15和60毫米的粘膜之间,最多50毫米的NACL,最多5毫米的CACL {SUB,2},以及50和1500 IU / ML之间的RFVIII。特别优选的配方包括用水复溶后的配方。 290毫米的甘氨酸,20毫米的组氨酸,30毫米的粘膜,30毫米的NACL,2.5毫米的CACL {SUB,2}以及50和1500 IU / ML RFVIII之间。冻干制剂的残留水含量约为。在重量的1%和3%之间,最好近似。重量的1%。

著录项

  • 公开/公告号ES2144293T3

    专利类型

  • 公开/公告日2000-06-01

    原文格式PDF

  • 申请/专利权人 BAYER CORPORATION;

    申请/专利号ES19970110631T

  • 发明设计人 NAYAR RAJIV;

    申请日1997-06-30

  • 分类号A61K38/37;C07K14/755;

  • 国家 ES

  • 入库时间 2022-08-22 01:53:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号